Therapeutic and Psychosocial Considerations of Transgender Patients (1718)

Jump to Content Jump to Main Navigation

Front Matter

Show Items
Automation and Information Technology–Positions

Show Items
Automation and Information Technology–Statements

Show Items
Automation and Information Technology–Guidelines

Show Items
Drug Distribution and Control–Positions

Show Items
Drug Distribution and Control–Guidelines

Show Items
Drug Distribution and Control: Procurement–Guidelines

Show Items
Drug Distribution and Control: Preparation and Handling–Positions

Show Items
Drug Distribution and Control: Preparation and Handling–Guidelines

Show Items
Drug Distribution and Control: Preparation and Handling–Technical Assistance Bulletin

Show Items
Drug Distribution and Control: Distribution–Positions

Show Items
Drug Distribution and Control: Distribution–Statements

Show Items
Drug Distribution and Control: Distribution–Technical Assistance Bulletins

Show Items
Education and Training–Positions

Show Items
Education and Training–Endorsed Document

Show Items
Ethics–Positions

Show Items
Ethics–Statements

Show Items
Ethics–Guideline

Show Items
Ethics–Endorsed Document

Show Items
Formulary Management (Medication-Use Policy Development)–Positions

Show Items
Formulary Management (Medication-Use Policy Development)–Statements

Show Items
Formulary Management (Medication-Use Policy Development)–Guidelines

Show Items
Formulary Management (Medication-Use Policy Development)–Endorsed Document

Show Items
Government, Law, and Regulation–Positions

Show Items
Government, Law, and Regulation–Statements

Show Items
Medication Safety–Positions

Show Items
Medication Safety–Statements

Show Items
Medication Safety–Guidelines

Show Items
Medication Therapy and Patient Care: Organization and Delivery of Services–Positions

Show Items
Medication Therapy and Patient Care: Organization and Delivery of Services–Statements

Show Items
Medication Therapy and Patient Care: Organization and Delivery of Services–Guidelines

Show Items
Medication Therapy and Patient Care: Specific Practice Areas–Positions
- Suicide Awareness and Prevention (1901)
- Therapeutic Use of Cannabidiol (1910)
- Safe Use and Effective Use of IV Promethazine (1831)
- Therapeutic and Psychosocial Considerations of Transgender Patients (1718)
- Pharmacist’s Leadership Role in Glycemic Control (1719)
- Pain Management (1722)
- Safe and Effective Therapeutic Use of Invertebrates (1724)
- Drug Dosing in Extracorporeal Therapies (1725)
- Safety of Intranasal Route as an Alternative Route of Administration (1601)
- Stewardship of Drugs with Potential for Abuse (1603)
- Appropriate Use of Antipsychotic Drug Therapies (1604)
- Safety of Epidural Steroid Injections (1605)
- Use of Methadone to Treat Pain (1607)
- Controlled Substance Diversion and Patient Access (1614)
- Tobacco, Tobacco Products, and Electronic Delivery Systems (1625)
- Naloxone Availability (1510)
- Safety and Effectiveness of Ethanol Treatment for Alcohol Withdrawal Syndrome (1514)
- Chemotherapy Parity (1516)
- Documentation of Penicillin Allergy as a Component of Antimicrobial Stewardship (1517)
- Prescription Drug Abuse (1526)
- Pharmacist’s Role in Urgent and Emergency Situations (1527)
- Appropriate Use of Testosterone (1536)
- Safe Use of Radiopharmaceuticals (1402)
- Safe Use of Fentanyl Transdermal System Patches (1404)
- Education About Performance-Enhancing Substances (1305)
- Pharmacists’ Role in Immunization (1309)
- Pharmacist’s Role in Accountable Care Organizations (1214)
- Criteria for Medication Use in Geriatric Patients (1221)
- Pharmacist’s Role in Providing Care for an Aging Population (0902)
- Pharmacist Role in the Health Care (Medical) Home (0908)
- Safe and Effective Use of Heparin in Neonatal Patients (0912)
- Pharmacist Support for Dying Patients (0307)
- Interventions to Reduce High-Risk Behavior in Intravenous Drug Users (9711)
Medication Therapy and Patient Care: Specific Practice Areas–Statements

Show Items
Medication Therapy and Patient Care: Specific Practice Areas–Guidelines

Show Items
Pharmaceutical Industry: Drug Products, Labeling, and Packaging–Positions

Show Items
Pharmaceutical Industry: Industry: Marketing–Positions

Show Items
Pharmaceutical Industry: Industry: Marketing–Guideline

Show Items
Pharmacy Management–Positions

Show Items
Pharmacy Management–Statements

Show Items
Pharmacy Management–Guidelines

Show Items
Pharmacy Management: Compensation and Reimbursement–Positions

Show Items
Pharmacy Management: Human Resources–Positions

Show Items
Pharmacy Management: Human Resources–Guideline

Show Items
Pharmacy Management: Human Resources–Report

Show Items
Practice Settings–Positions

Show Items
Practice Settings–Guidelines

Show Items
Research–Positions

Show Items
Research–Statement

Show Items
Research–Guidelines

Show Items
ASHP Therapeutic Position Statements

Show Items
ASHP Therapeutic Guidelines

Show Items
Back Matter

Show Items

Therapeutic and Psychosocial Considerations of Transgender Patients (1718)

in Best Practices

Editor:

Bruce Hawkins

DOI:: https://doi.org/10.37573/9781585286560.234

Restricted access

Share Link

Copy this link, or click below to email it to a friend

Email this content

or copy the link directly:

https://publications.ashp.org/abstract/book/9781585286560/ch234.xml

Link copied successfully

About ASHP Contact Us Correction Notices Customer Relations

FAQs Information for Authors Libraries and Institutions Rights and Permissions

Table of Contents

Therapeutic and Psychosocial Considerations of Transgender Patients (1718)

Share Link